BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12203944)

  • 1. Haemodynamics in microvascular complications in type 1 diabetes.
    Candido R; Allen TJ
    Diabetes Metab Res Rev; 2002; 18(4):286-304. PubMed ID: 12203944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy.
    Cooper ME
    Diabetologia; 2001 Nov; 44(11):1957-72. PubMed ID: 11719827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB
    Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.
    Abdul-Ghani M; Nawaf G; Nawaf F; Itzhak B; Minuchin O; Vardi P
    Isr Med Assoc J; 2006 Jun; 8(6):378-82. PubMed ID: 16833164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic nephropathy: where hemodynamics meets metabolism.
    Forbes JM; Fukami K; Cooper ME
    Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):69-84. PubMed ID: 17318765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvascular complications of diabetes.
    Cypress M; Tomky D
    Nurs Clin North Am; 2006 Dec; 41(4):719-36, ix. PubMed ID: 17059984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvascular hemodynamics in hypertension and diabetes.
    Tooke JE; Sandeman DD; Shore AC
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S51-3. PubMed ID: 1725043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients].
    Moleda P; Majkowska L; Safranow K; Adler G; Goracy I
    Przegl Lek; 2007; 64(3):134-9. PubMed ID: 17941464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of C-peptide on microvascular blood flow and blood hemorheology.
    Forst T; Kunt T
    Exp Diabesity Res; 2004; 5(1):51-64. PubMed ID: 15198371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevention of diabetic microvascular complications of diabetes: is there a role for lipid lowering?
    Leiter LA
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl 2():S3-14. PubMed ID: 15953505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Arterial hypertension and diabetes].
    Grimm JJ; Furrer J
    Schweiz Med Wochenschr Suppl; 1994; 60():43-6. PubMed ID: 8016612
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship between peripheral diabetic neuropathy and microvascular reactivity in patients with type 1 and type 2 diabetes mellitus -- neuropathy and microcirculation in diabetes.
    Kasalová Z; Prázný M; Skrha J
    Exp Clin Endocrinol Diabetes; 2006 Feb; 114(2):52-7. PubMed ID: 16570233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-sectional analysis of adult diabetes type 1 and type 2 patients with diabetic microvascular complications from a German retrospective observational study.
    Happich M; Breitscheidel L; Meisinger C; Ulbig M; Falkenstein P; Benter U; Watkins J
    Curr Med Res Opin; 2007 Jun; 23(6):1367-74. PubMed ID: 17559744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects for angiotensin receptor blockers in diabetic retinopathy.
    Sjølie AK
    Diabetes Res Clin Pract; 2007 May; 76 Suppl 1():S31-9. PubMed ID: 17321627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microvascular aspects of diabetic foot disease.
    Tooke JE; Brash PD
    Diabet Med; 1996; 13 Suppl 1():S26-9. PubMed ID: 8741825
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictors of development and progression of microvascular complications in a cohort of Brazilian type 2 diabetic patients.
    Cardoso CR; Salles GF
    J Diabetes Complications; 2008; 22(3):164-70. PubMed ID: 18413219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic microvascular complications: can patients at risk be identified? A review.
    Girach A; Manner D; Porta M
    Int J Clin Pract; 2006 Nov; 60(11):1471-83. PubMed ID: 17073842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic microvascular complications and growth factors.
    Pfeiffer A; Schatz H
    Exp Clin Endocrinol Diabetes; 1995; 103(1):7-14. PubMed ID: 7621107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypertension and diabetes: mechanisms of elevation of arterial pressure, physiopathologic basis of therapeutic antihypertensives].
    Mogensen CE
    Journ Annu Diabetol Hotel Dieu; 1993; ():161-88. PubMed ID: 8331863
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diabetic microangiopathy].
    García-Conde Gómez FJ
    An R Acad Nac Med (Madr); 1986; 103(2):173-89. PubMed ID: 3799953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.